Stockscreener 앱 받기
5.85
12.72%
0.66
시간 외 거래:
5.84
-0.010
-0.17%
Bioharvest Sciences Inc 주식(BHST)의 최신 뉴스
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025 - Newsfile
BioHarvest Sciences achieves breakthrough in Liver health with Olive Cell compound - Proactive Investors USA
BioHarvest’s Olive Cell Compound Shows Promise in Tackling Liver Fat Accumulation - TipRanks
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells - Newsfile
EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells - Benzinga
BioHarvest Sciences Inc. (NASDAQ:BHST) Not Flying Under The Radar - Simply Wall St
BioHarvest Sciences Inc.'s (NASDAQ:BHST) Shift From Loss To Profit - Yahoo Finance
BioHarvest Sciences surpasses 50 million dollars in VINIA sales, plans major production expansion - Proactive Investors USA
BioHarvest's VINIA sales top $50M, plans production boost By Investing.com - Investing.com Canada
BioHarvest’s VINIA Achieves $50 Million in Sales, Plans Major Expansion - TipRanks
BioHarvest's VINIA sales top $50M, plans production boost - Investing.com India
BioHarvest’s VINIA sales top $50M, plans production boost - Investing.com
BioHarvest’s VINIA sales top $50M, plans production boost By Investing.com - Investing.com Nigeria
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD - Newsfile
BioHarvest Sciences to Delist from CSE, Focuses on Nasdaq - TipRanks
CSE Bulletin: DelistBioHarvest Sciences Inc. (BHSC) - TradingView
BioHarvest CEO to present at WeBull Consumer Stocks Virtual Webinar - Proactive Investors USA
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar - TipRanks
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18 - Newsfile
Exclusive: Inside BioHarvest's Revolutionary Plant-Based TechnologyCEO Reveals Growth Strategy - StockTitan
Bioharvest Sciences to voluntarily delist from CSE - Proactive Investors Australia
BioHarvest Sciences to Delist from CSE, Focus on Nasdaq - TipRanks
When Will BioHarvest Sciences Inc. (CSE:BHSC) Become Profitable? - Simply Wall St
BioHarvest Sciences reports material change - Investing.com India
BioHarvest Sciences Appoints Sharon Malka to Board of Directors - TipRanks
BioHarvest Sciences reports material change By Investing.com - Investing.com UK
BioHarvest Sciences appoints veteran technology leader to board of directors - Proactive Investors UK
BioHarvest Announces Appointment of Sharon Malka to Board of Directors - Newsfile
Bioharvest Sciences Inc. Appoints Sharon Malka as Independent Director -January 22, 2025 at 08:34 am EST - Marketscreener.com
OTC Markets Group Announces Quarterly Index Performance and Rebalancing - GlobeNewswire Inc.
BioHarvest Sciences positioned for ‘legacy year’ in 2025, building on momentum with new innovations and strategic collaborations - Proactive Investors UK
BioHarvest Sciences doubles VINIA business, eyes growth By Investing.com - Investing.com Australia
CSE Bulletin: NV Issuer DesignationBioHarvest Sciences Inc. (BHSC) - Newsfile
BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growth - Proactive Investors UK
BioHarvest Sciences Unveils Strategic Growth Initiatives with New CDMO Division - TipRanks
BioHarvest Sciences doubles VINIA business, eyes growth - Investing.com
BioHarvest Issues Shareholder Letter and Provides Corporate Update - Yahoo Finance
BioHarvest Sciences (NASDAQ:BHST) Earns Buy Rating from Analysts at Maxim Group - Defense World
Maxim Group sets Buy rating on BioHarvest Sciences shares, cites robust growth - Investing.com India
1.66%
0.16%
자본화:
|
볼륨(24시간):